Primecap Management CO Bio N Tech Se Transaction History
Primecap Management CO
- $136 Billion
- Q2 2024
A detailed history of Primecap Management CO transactions in Bio N Tech Se stock. As of the latest transaction made, Primecap Management CO holds 4,789,518 shares of BNTX stock, worth $567 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
4,789,518
Previous 4,807,918
0.38%
Holding current value
$567 Million
Previous $444 Million
13.22%
% of portfolio
0.28%
Previous 0.34%
Shares
19 transactions
Others Institutions Holding BNTX
# of Institutions
328Shares Held
40.6MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$979 Million0.53% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$518 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$346 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$224 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$214 Million0.68% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.7B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...